Page last updated: 2024-11-02

pentamidine and Bacterial Infections, Gram-Negative

pentamidine has been researched along with Bacterial Infections, Gram-Negative in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research Excerpts

ExcerptRelevanceReference
" However, little attention has been paid in previous clinical studies to actual dosage and regional distribution of aerosolized antibiotics in the lung and the pharmacokinetics of the aerosol after deposition."2.38Delivery of topical antibiotics: pharmacokinetics and clinical problems. ( Fein, AM; Ilowite, JS; Niederman, MS, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wu, C1
Xia, L1
Huang, W1
Xu, Y1
Gu, Y1
Liu, C1
Ji, L1
Li, W1
Wu, Y1
Zhou, K1
Feng, X1
Ilowite, JS1
Niederman, MS1
Fein, AM1

Reviews

1 review available for pentamidine and Bacterial Infections, Gram-Negative

ArticleYear
Delivery of topical antibiotics: pharmacokinetics and clinical problems.
    Seminars in respiratory infections, 1991, Volume: 6, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Cro

1991

Other Studies

1 other study available for pentamidine and Bacterial Infections, Gram-Negative

ArticleYear
Pentamidine sensitizes FDA-approved non-antibiotics for the inhibition of multidrug-resistant Gram-negative pathogens.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Drug Repositioning; Drug Resistance, Multipl

2020